# Albania Chemicals Export Opportunities (HS 28-38)

![Yugalinks](https://www.yugalinks.com/trade/yugalinks-logo-v3-dark-mode.webp)

> Yugalinks sector export playbook

Explore Albania HS 28-38 chemicals export opportunities, product portfolio, buyer markets, growth signals, and diversification opportunities.

## Overview

- Exporter: Albania (ALB)
- Sector: Chemicals
- HS chapters: HS 28-38
- Latest trade year: 2024
- Sector exports: $4.8M
- Products: 19
- Buyer markets: 20
- Average CAGR: +0.9%
- Global sector size: $514.8B

## Product portfolio

| Product | Global size | Your exports | Opportunity | CAGR | Markets | Share |
| --- | ---: | ---: | ---: | ---: | ---: | ---: |
| HS 300490 - Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $265.3B | $28.0K | $103.4B | -17.3% | 17 | +0.0% |
| HS 300215 - Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail sale | $103.6B | $314.7K | $38.2B | +1.2% | 5 | +0.0% |
| HS 300212 - Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions | $25.3B | $27.4K | $13.6B | +61.2% | 4 | +0.0% |
| HS 382499 - Chemical products, mixtures and preparations: n.e.c. heading 3824 | $23.0B | $161.1K | $13.5B | -2.0% | 8 | +0.0% |
| HS 300220 - Vaccines: for human medicine | $16.0B | $2.2K | $11.1B | -13.0% | 3 | +0.0% |
| HS 330499 - Cosmetic and toilet preparations: n.e.c. in heading no. 3304, for the care of the skin (excluding medicaments, including sunscreen or sun tan preparations) | $21.9B | $11.6K | $9.3B | +9.7% | 6 | +0.0% |
| HS 300439 - Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | $16.3B | $70.1 | $7.9B | +0.1% | 4 | +0.0% |
| HS 382200 - Reagents: diagnostic or laboratory reagents on a backing and prepared diagnostic or laboratory reagents whether or not on a backing, other than those of heading no. 3002 or 3006: certified reference material | $13.5B | $3.2K | $5.4B | +9.4% | 4 | +0.0% |
| HS 293499 - Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 | $5.8B | $16.4 | $4.6B | +18.1% | 1 | +0.0% |
| HS 330300 - Perfumes and toilet waters | $4.9B | $53.4K | $3.0B | +17.5% | 3 | +0.0% |
| HS 382600 - Biodiesel and mixtures thereof: not containing or containing less than 70% by weight of petroleum oils or oils obtained from bituminous minerals | $3.3B | $4.1M | $3.0B | -24.6% | 2 | +0.3% |
| HS 340220 - Washing and cleaning preparations: surface-active, whether or not containing soap (excluding those of heading no. 3401), put up for retail sale | $2.3B | $234.7 | $2.1B | -0.9% | 2 | +0.0% |
| HS 300420 - Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | $3.8B | $170.2 | $2.0B | +66.0% | 1 | +0.0% |
| HS 300290 - Toxins, cultures of micro-organisms (excluding yeasts) and similar products | $3.6B | $158.0 | $1.8B | +3.2% | 2 | +0.0% |
| HS 290110 - Acyclic hydrocarbons: saturated | $916.4M | $5.7 | $1.3B | +26.7% | 1 | +0.0% |
| HS 300390 - Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | $2.0B | $22.8 | $981.1M | -6.5% | 1 | +0.0% |
| HS 293339 - Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its salts | $1.6B | $186.6K | $871.0M | -2.0% | 1 | +0.0% |
| HS 330290 - Odoriferous substances and mixtures: used as raw materials in industries other than the food or drink industries | $1.3B | $654.1 | $803.3M | -27.4% | 1 | +0.0% |
| HS 330210 - Odoriferous substances and mixtures: of a kind used in the food or drink industries | $667.8M | $15.2 | $720.6M | -20.2% | 1 | +0.0% |

## Best markets

- USA, Puerto Rico and US Virgin Islands (USA): $73.5B calculated opportunity across 12 products.
- Switzerland, Liechtenstein (CHE): $31.0B calculated opportunity across 2 products.
- Germany (DEU): $28.2B calculated opportunity across 12 products.
- Netherlands (NLD): $11.5B calculated opportunity across 3 products.
- Slovenia (SVN): $9.7B calculated opportunity across 1 products.
- United Kingdom (GBR): $9.1B calculated opportunity across 5 products.
- Canada (CAN): $9.0B calculated opportunity across 6 products.
- Spain (ESP): $8.8B calculated opportunity across 5 products.
- France (FRA): $8.1B calculated opportunity across 5 products.
- China (CHN): $7.1B calculated opportunity across 2 products.
- Belgium (BEL): $7.0B calculated opportunity across 1 products.
- Italy (ITA): $6.3B calculated opportunity across 3 products.

## Growth stars

- HS 300420: +66.0% average CAGR, $2.0B calculated opportunity.
- HS 300212: +61.2% average CAGR, $13.6B calculated opportunity.
- HS 290110: +26.7% average CAGR, $1.3B calculated opportunity.
- HS 293499: +18.1% average CAGR, $4.6B calculated opportunity.
- HS 330300: +17.5% average CAGR, $3.0B calculated opportunity.
- HS 330499: +9.7% average CAGR, $9.3B calculated opportunity.
- HS 382200: +9.4% average CAGR, $5.4B calculated opportunity.
- HS 300290: +3.2% average CAGR, $1.8B calculated opportunity.
- HS 300215: +1.2% average CAGR, $38.2B calculated opportunity.
- HS 300439: +0.1% average CAGR, $7.9B calculated opportunity.

## Diversification opportunities

- HS 300490: 17 buyer markets, $103.4B calculated opportunity.
- HS 382499: 8 buyer markets, $13.5B calculated opportunity.
- HS 330499: 6 buyer markets, $9.3B calculated opportunity.
- HS 300215: 5 buyer markets, $38.2B calculated opportunity.
- HS 300212: 4 buyer markets, $13.6B calculated opportunity.
- HS 300439: 4 buyer markets, $7.9B calculated opportunity.
- HS 382200: 4 buyer markets, $5.4B calculated opportunity.
- HS 300220: 3 buyer markets, $11.1B calculated opportunity.
- HS 330300: 3 buyer markets, $3.0B calculated opportunity.
- HS 382600: 2 buyer markets, $3.0B calculated opportunity.

## Method

Reported trade observations and calculated indicators are shown separately. Validate buyers, standards, logistics, pricing, and competition before acting. [Read the Yugalinks methodology](https://www.yugalinks.com/methodology).

## Data sources

- Primary trade series: OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). [OECD Data Explorer](https://data-explorer.oecd.org/) - [OECD Terms & Conditions](https://www.oecd.org/termsandconditions/)
- CEPII BACI bilateral trade flows (202601): [dataset page](https://www.cepii.fr/CEPII/en/bdd_modele/bdd_modele_item.asp?id=37) - [BACI documentation](https://www.cepii.fr/DATA_DOWNLOAD/baci/doc/baci_webpage.html) - [Etalab 2.0 Open Licence](https://www.etalab.gouv.fr/wp-content/uploads/2018/11/open-licence.pdf)

This page presents derived Yugalinks views of reported observations and calculated indicators.